全球性行為感染傳染病 (STD) 檢測市場 (2024-2028)

性行為感染傳染病（STD）檢測市場（2024-2028）

2023年至2028年，性行為感染傳染病（STD）檢測市場預計將擴大323.7億美元，預測期內複合年成長率為5.6%。該報告包括對性行為感染傳染病 (STD) 檢測市場的總體分析、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

該報告提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。這一市場的推動因素包括性傳染病的日益普及、有利的報銷政策的存在以及世界各國政府不斷採取的舉措。

該報告將性行為感染傳染病（STD）快速診斷的進步確定為未來幾年推動性傳染病（STD）檢測市場成長的關鍵因素之一。此外，越來越多的組織參與以提高人們對性傳染病和快速合作夥伴治療 (EPT) 的認知，也導致了市場的巨大需求。

目錄

第1章執行摘要

• 市場概況

第2章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第3章 市場規模評估

• 市場定義
• 細分市場分析
• 市場規模（2023年）
• 市場展望（2023-2028）

第4章 市場規模表現

• 全球性行為感染傳染病（STD）檢測市場（2018-2022）
• 按產品分析（2018-2022）
• 依疾病類型分析（2018-2022）
• 區域分析（2018-2022）
• 國家分析（2018-2022）

第5章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第6章 依產品細分市場

• 市場區隔
• 比較：按產品
• 實驗室測試設備：市場規模及預測（2023-2028）
• PoC測試設備：市場規模及預測（2023-2028）
• 按產品分類的市場機會

第7章 按疾病類型細分市場

• 市場區隔
• 比較：依疾病類型
• 披衣菌感染：市場規模與預測（2023-2028）
• 淋病：市場規模與預測（2023-2028）
• 梅毒：市場規模與預測（2023-2028）
• 滴蟲病：市場規模與預測（2023-2028）
• 其他：市場規模及預測（2023-2028）
• 按疾病類型分類的市場機會

第8章 客戶狀況

• 客戶狀況概覽

第9章 地區情勢

• 區域細分
• 區域比較
• 北美：市場規模與預測（2023-2028）
• 歐洲：市場規模與預測（2023-2028）
• 亞洲：市場規模與預測（2023-2028）
• 世界其他地區：市場規模與預測（2023-2028）
• 美國：市場規模與預測（2023-2028）
• 德國：市場規模與預測（2023-2028）
• 英國：市場規模與預測（2023-2028）
• 加拿大：市場規模與預測（2023-2028）
• 中國：市場規模及預測（2023-2028）
• 按地區分類的市場機會

第10章 促進因素、挑戰、機會、限制因素

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機會與限制

第11章競爭格局

• 概述
• 競爭格局
• 混亂的情況
• 產業風險

第12章 競爭分析

• 公司簡介
• 公司市場定位
• AbbVie Inc.
• AccuBioTech Co. Ltd.
• AdvaCare Pharma
• BIOGENIX Inc. Pvt. Ltd.
• F. Hoffmann La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Hologic Inc.
• Inovio Pharmaceuticals Inc.
• Johnson and Johnson Services Inc.
• Merck and Co. Inc.
• Ok Biotech Co Ltd.
• Priority STD Testing
• QIAGEN NV
• RayBiotech Life Inc.

第13章附錄

Sexually Transmitted Disease (STD) Testing Market 2024-2028

The sexually transmitted disease (STD) testing market is forecasted to grow by USD 32.37 bn during 2023-2028, accelerating at a CAGR of 5.6% during the forecast period. The report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of STDs, presence of favorable reimbursement policies, and increased initiatives by governments worldwide.

Technavio's sexually transmitted disease (STD) testing market is segmented as below:

By Product

• Laboratory testing device
• POC testing device

By Disease Type

• Chlamydia
• Gonorrhea
• Syphilis
• Trichomoniasis
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in rapid diagnosis of STDs as one of the prime reasons driving the sexually transmitted disease (STD) testing market growth during the next few years. Also, increasing involvement of various organizations to create awareness about STDs and expedited partner therapy (EPT) will lead to sizable demand in the market.

The report on the sexually transmitted disease (STD) testing market covers the following areas:

• Sexually transmitted disease (STD) testing market sizing
• Sexually transmitted disease (STD) testing market forecast
• Sexually transmitted disease (STD) testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted disease (STD) testing market vendors that include AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Goffin Molecular Technologies, Hangzhou Biotest Biotech, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., LT Labs, Merck and Co. Inc., Ok Biotech Co Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc.. Also, the sexually transmitted disease (STD) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Sexually Transmitted Disease (STD) Testing Market 2018 - 2022
  • Historic Market Size - Data Table on Global Sexually Transmitted Disease (STD) Testing Market 2018 - 2022 ($ billion)
• 4.2 Product segment analysis 2018 - 2022
  • Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.3 Disease Type segment analysis 2018 - 2022
  • Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
  • Chart on Product - Market share 2023-2028 (%)
  • Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 6.3 Laboratory testing device - Market size and forecast 2023-2028
  • Chart on Laboratory testing device - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Laboratory testing device - Market size and forecast 2023-2028 ($ billion)
  • Chart on Laboratory testing device - Year-over-year growth 2023-2028 (%)
  • Data Table on Laboratory testing device - Year-over-year growth 2023-2028 (%)
• 6.4 POC testing device - Market size and forecast 2023-2028
  • Chart on POC testing device - Market size and forecast 2023-2028 ($ billion)
  • Data Table on POC testing device - Market size and forecast 2023-2028 ($ billion)
  • Chart on POC testing device - Year-over-year growth 2023-2028 (%)
  • Data Table on POC testing device - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product
  • Market opportunity by Product ($ billion)
  • Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Disease Type

• 7.1 Market segments
  • Chart on Disease Type - Market share 2023-2028 (%)
  • Data Table on Disease Type - Market share 2023-2028 (%)
• 7.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type
• 7.3 Chlamydia - Market size and forecast 2023-2028
  • Chart on Chlamydia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Chlamydia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Chlamydia - Year-over-year growth 2023-2028 (%)
  • Data Table on Chlamydia - Year-over-year growth 2023-2028 (%)
• 7.4 Gonorrhea - Market size and forecast 2023-2028
  • Chart on Gonorrhea - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Gonorrhea - Market size and forecast 2023-2028 ($ billion)
  • Chart on Gonorrhea - Year-over-year growth 2023-2028 (%)
  • Data Table on Gonorrhea - Year-over-year growth 2023-2028 (%)
• 7.5 Syphilis - Market size and forecast 2023-2028
  • Chart on Syphilis - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Syphilis - Market size and forecast 2023-2028 ($ billion)
  • Chart on Syphilis - Year-over-year growth 2023-2028 (%)
  • Data Table on Syphilis - Year-over-year growth 2023-2028 (%)
• 7.6 Trichomoniasis - Market size and forecast 2023-2028
  • Chart on Trichomoniasis - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Trichomoniasis - Market size and forecast 2023-2028 ($ billion)
  • Chart on Trichomoniasis - Year-over-year growth 2023-2028 (%)
  • Data Table on Trichomoniasis - Year-over-year growth 2023-2028 (%)
• 7.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.8 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ billion)
  • Data Table on Market opportunity by Disease Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
• 12.4 AccuBioTech Co. Ltd.
  • AccuBioTech Co. Ltd. - Overview
  • AccuBioTech Co. Ltd. - Product / Service
  • AccuBioTech Co. Ltd. - Key offerings
• 12.5 AdvaCare Pharma
  • AdvaCare Pharma - Overview
  • AdvaCare Pharma - Product / Service
  • AdvaCare Pharma - Key offerings
• 12.6 BIOGENIX Inc. Pvt. Ltd.
  • BIOGENIX Inc. Pvt. Ltd. - Overview
  • BIOGENIX Inc. Pvt. Ltd. - Product / Service
  • BIOGENIX Inc. Pvt. Ltd. - Key offerings
• 12.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Gilead Sciences Inc.
  • Gilead Sciences Inc. - Overview
  • Gilead Sciences Inc. - Product / Service
  • Gilead Sciences Inc. - Key news
  • Gilead Sciences Inc. - Key offerings
• 12.9 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.10 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Business segments
  • Hologic Inc. - Key news
  • Hologic Inc. - Key offerings
  • Hologic Inc. - Segment focus
• 12.11 Inovio Pharmaceuticals Inc.
  • Inovio Pharmaceuticals Inc. - Overview
  • Inovio Pharmaceuticals Inc. - Product / Service
  • Inovio Pharmaceuticals Inc. - Key news
  • Inovio Pharmaceuticals Inc. - Key offerings
• 12.12 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.13 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.14 Ok Biotech Co Ltd.
  • Ok Biotech Co Ltd. - Overview
  • Ok Biotech Co Ltd. - Product / Service
  • Ok Biotech Co Ltd. - Key offerings
• 12.15 Priority STD Testing
  • Priority STD Testing - Overview
  • Priority STD Testing - Product / Service
  • Priority STD Testing - Key offerings
• 12.16 QIAGEN NV
  • QIAGEN NV - Overview
  • QIAGEN NV - Product / Service
  • QIAGEN NV - Key news
  • QIAGEN NV - Key offerings
• 12.17 RayBiotech Life Inc.
  • RayBiotech Life Inc. - Overview
  • RayBiotech Life Inc. - Product / Service
  • RayBiotech Life Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Sexually Transmitted Disease (STD) Testing Market 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Product - Market share 2023-2028 (%)
• Exhibits33: Data Table on Product - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Product
• Exhibits35: Data Table on Comparison by Product
• Exhibits36: Chart on Laboratory testing device - Market size and forecast 2023-2028 ($ billion)
• Exhibits37: Data Table on Laboratory testing device - Market size and forecast 2023-2028 ($ billion)
• Exhibits38: Chart on Laboratory testing device - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Laboratory testing device - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on POC testing device - Market size and forecast 2023-2028 ($ billion)
• Exhibits41: Data Table on POC testing device - Market size and forecast 2023-2028 ($ billion)
• Exhibits42: Chart on POC testing device - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on POC testing device - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Product ($ billion)
• Exhibits45: Data Table on Market opportunity by Product ($ billion)
• Exhibits46: Chart on Disease Type - Market share 2023-2028 (%)
• Exhibits47: Data Table on Disease Type - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by Disease Type
• Exhibits49: Data Table on Comparison by Disease Type
• Exhibits50: Chart on Chlamydia - Market size and forecast 2023-2028 ($ billion)
• Exhibits51: Data Table on Chlamydia - Market size and forecast 2023-2028 ($ billion)
• Exhibits52: Chart on Chlamydia - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Chlamydia - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on Gonorrhea - Market size and forecast 2023-2028 ($ billion)
• Exhibits55: Data Table on Gonorrhea - Market size and forecast 2023-2028 ($ billion)
• Exhibits56: Chart on Gonorrhea - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on Gonorrhea - Year-over-year growth 2023-2028 (%)
• Exhibits58: Chart on Syphilis - Market size and forecast 2023-2028 ($ billion)
• Exhibits59: Data Table on Syphilis - Market size and forecast 2023-2028 ($ billion)
• Exhibits60: Chart on Syphilis - Year-over-year growth 2023-2028 (%)
• Exhibits61: Data Table on Syphilis - Year-over-year growth 2023-2028 (%)
• Exhibits62: Chart on Trichomoniasis - Market size and forecast 2023-2028 ($ billion)
• Exhibits63: Data Table on Trichomoniasis - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Chart on Trichomoniasis - Year-over-year growth 2023-2028 (%)
• Exhibits65: Data Table on Trichomoniasis - Year-over-year growth 2023-2028 (%)
• Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits70: Market opportunity by Disease Type ($ billion)
• Exhibits71: Data Table on Market opportunity by Disease Type ($ billion)
• Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits75: Chart on Geographic comparison
• Exhibits76: Data Table on Geographic comparison
• Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits109: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits110: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits111: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits112: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits113: Market opportunity By Geographical Landscape ($ billion)
• Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits115: Impact of drivers and challenges in 2023 and 2028
• Exhibits116: Overview on criticality of inputs and factors of differentiation
• Exhibits117: Overview on factors of disruption
• Exhibits118: Impact of key risks on business
• Exhibits119: Companies covered
• Exhibits120: Matrix on companies position and classification
• Exhibits121: AbbVie Inc. - Overview
• Exhibits122: AbbVie Inc. - Product / Service
• Exhibits123: AbbVie Inc. - Key news
• Exhibits124: AbbVie Inc. - Key offerings
• Exhibits125: AccuBioTech Co. Ltd. - Overview
• Exhibits126: AccuBioTech Co. Ltd. - Product / Service
• Exhibits127: AccuBioTech Co. Ltd. - Key offerings
• Exhibits128: AdvaCare Pharma - Overview
• Exhibits129: AdvaCare Pharma - Product / Service
• Exhibits130: AdvaCare Pharma - Key offerings
• Exhibits131: BIOGENIX Inc. Pvt. Ltd. - Overview
• Exhibits132: BIOGENIX Inc. Pvt. Ltd. - Product / Service
• Exhibits133: BIOGENIX Inc. Pvt. Ltd. - Key offerings
• Exhibits134: F. Hoffmann La Roche Ltd. - Overview
• Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits136: F. Hoffmann La Roche Ltd. - Key news
• Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits139: Gilead Sciences Inc. - Overview
• Exhibits140: Gilead Sciences Inc. - Product / Service
• Exhibits141: Gilead Sciences Inc. - Key news
• Exhibits142: Gilead Sciences Inc. - Key offerings
• Exhibits143: GlaxoSmithKline Plc - Overview
• Exhibits144: GlaxoSmithKline Plc - Business segments
• Exhibits145: GlaxoSmithKline Plc - Key news
• Exhibits146: GlaxoSmithKline Plc - Key offerings
• Exhibits147: GlaxoSmithKline Plc - Segment focus
• Exhibits148: Hologic Inc. - Overview
• Exhibits149: Hologic Inc. - Business segments
• Exhibits150: Hologic Inc. - Key news
• Exhibits151: Hologic Inc. - Key offerings
• Exhibits152: Hologic Inc. - Segment focus
• Exhibits153: Inovio Pharmaceuticals Inc. - Overview
• Exhibits154: Inovio Pharmaceuticals Inc. - Product / Service
• Exhibits155: Inovio Pharmaceuticals Inc. - Key news
• Exhibits156: Inovio Pharmaceuticals Inc. - Key offerings
• Exhibits157: Johnson and Johnson Services Inc. - Overview
• Exhibits158: Johnson and Johnson Services Inc. - Business segments
• Exhibits159: Johnson and Johnson Services Inc. - Key news
• Exhibits160: Johnson and Johnson Services Inc. - Key offerings
• Exhibits161: Johnson and Johnson Services Inc. - Segment focus
• Exhibits162: Merck and Co. Inc. - Overview
• Exhibits163: Merck and Co. Inc. - Business segments
• Exhibits164: Merck and Co. Inc. - Key news
• Exhibits165: Merck and Co. Inc. - Key offerings
• Exhibits166: Merck and Co. Inc. - Segment focus
• Exhibits167: Ok Biotech Co Ltd. - Overview
• Exhibits168: Ok Biotech Co Ltd. - Product / Service
• Exhibits169: Ok Biotech Co Ltd. - Key offerings
• Exhibits170: Priority STD Testing - Overview
• Exhibits171: Priority STD Testing - Product / Service
• Exhibits172: Priority STD Testing - Key offerings
• Exhibits173: QIAGEN NV - Overview
• Exhibits174: QIAGEN NV - Product / Service
• Exhibits175: QIAGEN NV - Key news
• Exhibits176: QIAGEN NV - Key offerings
• Exhibits177: RayBiotech Life Inc. - Overview
• Exhibits178: RayBiotech Life Inc. - Product / Service
• Exhibits179: RayBiotech Life Inc. - Key offerings
• Exhibits180: Inclusions checklist
• Exhibits181: Exclusions checklist
• Exhibits182: Currency conversion rates for US$
• Exhibits183: Research methodology
• Exhibits184: Information sources
• Exhibits185: Data validation
• Exhibits186: Validation techniques employed for market sizing
• Exhibits187: Data synthesis
• Exhibits188: 360 degree market analysis
• Exhibits189: List of abbreviations